Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Lamin B2 (internal) Antibody | Login | Anti-Lamin B2 (internal) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Ku80 (internal) Antibody | Login | Anti-Ku80 (internal) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Fumarate hydratase (internal) Antibody | Login | Anti-Fumarate hydratase (internal) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Fatty Acid Synthase (N-term) Antibody | Login | Anti-Fatty Acid Synthase (N-term) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-cGK1 alpha Antibody | Login | Anti-cGK1 alpha Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Lamin A/C Antibody | Login | Anti-Lamin A/C Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-SMC1B Antibody | Login | Anti-SMC1B Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-cyclin T2 (C-term) Antibody | Login | Anti-cyclin T2 (C-term) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-TRPM2 (N-term) Antibody | Login | Anti-TRPM2 (N-term) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-alpha amylase 2A (pancreatic) Antibody | Login | Anti-alpha amylase 2A (pancreatic) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-RPA32 Antibody | Login | Anti-RPA32 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Annexin A1 Antibody | Login | Anti-Annexin A1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-HLA-DR Antibody | Login | Anti-HLA-DR Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-hnRNP C1/C2 Antibody | Login | Anti-hnRNP C1/C2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-NAT1 Antibody | Login | Anti-NAT1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-HNF1 alpha Antibody | Login | Anti-HNF1 alpha Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-UGT1A6 Antibody | Login | Anti-UGT1A6 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-UGT1A9 Antibody | Login | Anti-UGT1A9 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-AMPK gamma 2 (C-term) Antibody | Login | Anti-AMPK gamma 2 (C-term) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-RALA Antibody | Login | Anti-RALA Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-hnRNP F Antibody | Login | Anti-hnRNP F Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-PCBP2 Antibody | Login | Anti-PCBP2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Histone H3.3B Antibody | Login | Anti-Histone H3.3B Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Progesterone Receptor (N-term) Antibody | Login | Anti-Progesterone Receptor (N-term) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mesothelin Antibody | Login | Anti-Mesothelin Antibody | ||||||||||||||||
|
||||||||||||||||||


